Repligen Corporation

(RGEN) Trade

By |

Profile

Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in the United States.

Contact Information

Website: www.repligen.com
Email: investors@repligen.com
Main Phone: +1 781 250-0111
Address: 41 Seyon Street, Building 1
Address 2: Suite 100
State: MA
City / Town: Waltham
Country: USA
Postal Code: 02453

Issuer Information

Exchange: NGS
CEO: Tony J. Hunt
Employees: 761
NAICS: Surgical and Medical Instrument Manufacturing(339112)

Equities News

Profile

Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in the United States.

Contact Information

Website: www.repligen.com
Email: investors@repligen.com
Main Phone: +1 781 250-0111
Address: 41 Seyon Street, Building 1
Address 2: Suite 100
State: MA
City / Town: Waltham
Country: USA
Postal Code: 02453

Issuer Information

Exchange: NGS
CEO: Tony J. Hunt
Employees: 761
NAICS: Surgical and Medical Instrument Manufacturing(339112)

Equities News

$ 133.35 $ -6.16 (-4.42%)
Last Price 133.35 Change $ -6.16 Change % -4.42 Tick N/A
Bid 116.00 Bid Size 300.00 Ask 143.64 Ask Size 200.00
Open 143.64 High 143.64 Low 133.06 Prev Close 139.51
Last Trade Volume 545,477 52 Wk Hi 143.93 52 Wk Low 68.39
Market Cap 7 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 52,305,744.00 EPS (TTM) 0.45 PE Ratio 310.00 Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 20 36
Number of Buys 9 17
Number of Sells 11 19
Net Activity -248955 -1452880
Last 10 Buys Shares
Karen A. Dawes 1,000
Glenn L. Cooper 1,000
Glenn L. Cooper 1,000
Glenn L. Cooper 1,000
Michael A. Griffith 1,000
Michael A. Griffith 1,000
Michael A. Griffith 1,000
Karen A. Dawes 1,000
Alfred L. Goldberg 1,000
Earl W. Henry 1,000
Last 10 Sell Shares
Thomas F. Ryan 1,000
Tony J. Hunt 1,000
Roy T. Eddleman 1,000
Karen A. Dawes 1,000
Roy T. Eddleman 1,000
Roy T. Eddleman 1,000
Nicolas M. Barthelemy 1,000
Roy T. Eddleman 1,000
Roy T. Eddleman 1,000
Thomas F. Ryan 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 50 50 50 50
Low Target Price Estimate 40 40 40 40
Mean Target Price Estimate 46.29 46.29 46.29 46.29
Standard Deviation 3.45 3.45 3.45 3.45
Date of Most Recent Estimate 06/04/18 05/09/18 05/09/18 06/04/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 6 6 6 6
Moderate Buy 1 1 1 1
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.38 1.38 1.38 1.38